Protective roles of thrombomodulin in cisplatin-induced nephrotoxicity through the inhibition of oxidative and endoplasmic reticulum stress

Abstract Cisplatin is an effective chemotherapeutic agent widely used for the treatment of various solid tumors. However, cisplatin has an important limitation in its use; currently, there is no method to ameliorate cisplatin-induced acute kidney injury (AKI). Thrombomodulin (TM) is well known not o...

Full description

Bibliographic Details
Published in:	Scientific Reports
Main Authors:	Hiroki Yamamoto, Yuko Ishida, Siying Zhang, Miyu Osako, Mizuho Nosaka, Yumi Kuninaka, Akiko Ishigami, Yuya Iwahashi, Miki Aragane, Lennon Matsumoto, Akihiko Kimura, Toshikazu Kondo
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-06-01
Subjects:	Cisplatin Acute kidney injury Thrombomodulin Tubular cells Mice
Online Access:	https://doi.org/10.1038/s41598-024-64619-y

Similar Items

Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures
by: Mallorie Boron, et al.
Published: (2022-07-01)

The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic Syndrome
by: Sarah Kröller, et al.
Published: (2024-09-01)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
by: Hayakawa M
Published: (2017-12-01)

Thrombomodulin: A key regulator of intravascular blood coagulation, fibrinolysis, and inflammation, and a treatment for disseminated intravascular coagulation
by: Koji SUZUKI
Published: (2024-12-01)

Value of Serum Thrombomodulin as a Marker and Predictor in Patients with Sepsis-Associated Acute Kidney Injury
by: Nguyen VT, et al.
Published: (2023-07-01)

Thrombomodulin and Lactate Dehydrogenase as Potential Predictors of Leg Ulcers in Sickle Cell Disease
by: Helen C. Okoye, et al.
Published: (2025-01-01)

Association of thrombomodulin with the severity of chronic kidney disease: a cross-sectional study
by: Ming Guo, et al.
Published: (2025-05-01)

Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
Published: (2013-05-01)

Evaluation of thrombomodulin (THBD) plasma levels in sickle cell disease and correlation with disease severity
by: Yasmeen M.M. Selim, et al.
Published: (2025-06-01)

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms
by: Luca L. G. Janssen, et al.
Published: (2024-07-01)

Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure
by: Zhou X, et al.
Published: (2024-03-01)

Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries
by: Tadahiro Goto, et al.
Published: (2022-05-01)

Endothelial Injury-Induced Shedding of Thrombomodulin as a Biomarker for Predicting Adverse Prognosis in Sepsis
by: Meng X, et al.
Published: (2025-09-01)

Coagulofibrinolytic effects of recombinant soluble thrombomodulin in prolonged porcine cardiac arrest
by: Boya Zhang, et al.
Published: (2023-12-01)

Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis
by: Takaaki Totoki, et al.
Published: (2024-01-01)

Persisting thrombomodulin resistance at 3 months after liver transplantation in children with cirrhosis
by: Marie-Astrid van Dievoet, et al.
Published: (2025-02-01)

Thrombomodulin Serum Levels—A Predictable Biomarker for the Acute Onset of Ischemic Stroke
by: Andrei-Lucian Zaharia, et al.
Published: (2024-01-01)

Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus
by: Yuko Okano, et al.
Published: (2021-08-01)

Combination of antithrombin and soluble thrombomodulin for early prediction of sepsis-Induced disseminated intravascular coagulation
by: Huan Zeng, et al.
Published: (2025-10-01)

Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Takuma Isshiki, et al.
Published: (2019-05-01)

The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity
by: Chien-Yu Huang, et al.
Published: (2023-05-01)

Plasma thrombomodulin is a valuable biomarker to predict the severity of hemorrhagic fever with renal syndrome caused by the Hantaan virus
by: Han-Dong Zhao, et al.
Published: (2025-04-01)

Effects of recombinant human soluble thrombomodulin on neutrophil extracellular traps in the kidney of a mouse model of endotoxin shock
by: Tatsuhiko Harada, et al.
Published: (2023-08-01)

Thrombomodulin resistance as a novel prothrombotic pathway in COVID-19
by: Ana Marco-Rico, et al.
Published: (2025-08-01)

Endotheliopathy, Soluble Thrombomodulin and Its Role in Predicting Prognosis in Severe Coronavirus Disease-2019 Pneumonia
by: Hanife Usta Atmaca, et al.
Published: (2023-08-01)

A retrospective study on safety and efficacy of recombinant human soluble thrombomodulin to acute aortic dissection with disseminated intravascular coagulation
by: Tsukasa Ikeda, et al.
Published: (2024-09-01)

Analysis of soluble thrombomodulin contents in blood serum of patients with non-valvular atrial fibrillation: gender dependence
by: O. N. Ogurkova, et al.
Published: (2025-01-01)

Absence of the lectin-like domain of thrombomodulin reduces HSV-1 lethality of mice with increased microglia responses
by: Meng-Shan Tsai, et al.
Published: (2022-03-01)

Thrombomodulin activation driven by LXR agonist attenuates renal injury in diabetic nephropathy
by: Wei Wang, et al.
Published: (2023-01-01)

Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis
by: Atsushi Okuda, et al.
Published: (2018-07-01)

Trans-ethnic Mendelian randomization analysis of membranous nephropathy and peripheral artery disease with mediating effects of thrombomodulin
by: Juhong Pan, et al.
Published: (2025-05-01)

Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening
by: Takayuki Okamoto, et al.
Published: (2020-07-01)

Forensic application of epidermal expression of HSP27 and HSP70 for the determination of wound vitality in human compressed neck skin
by: Siying Zhang, et al.
Published: (2023-04-01)

The chondroitin sulfate moiety mediates thrombomodulin-enhanced adhesion and migration of vascular smooth muscle cells
by: Vincent Chunpeng Pai, et al.
Published: (2018-02-01)

Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients
by: Michael Hultström, et al.
Published: (2022-06-01)

Effects of thrombomodulin alfa on hemostatic parameters in disseminated intravascular coagulation: Post hoc analysis of a phase 3 randomized controlled trial
by: Takashi Ito, et al.
Published: (2020-10-01)

Whole exome sequencing identifies a mutation in thrombomodulin as the genetic cause of a suspected platelet disorder in a family with normal platelet function
by: Annabel Maclachlan, et al.
Published: (2017-08-01)

MiR-550a-3p restores damaged vascular smooth muscle cells by inhibiting thrombomodulin in an <em>in vitro</em> atherosclerosis model
by: Shiyuan Chen, et al.
Published: (2022-07-01)

Thrombomodulin and von willebrand factor as markers of endothelial dysfunction in patients with chronic kidney disease
by: I. S. Mykhaloiko, et al.
Published: (2022-04-01)

A thrombomodulin-like gene is crucial to the collective migration of epibolic blastomeres during germ layer formation and organogenesis in zebrafish
by: Gang-Hui Lee, et al.
Published: (2019-08-01)